Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study.

Kadoya T, Aogi K, Kiyoto S, Masumoto N, Sugawara Y, Okada M.

Breast Cancer Res Treat. 2013 Sep;141(2):269-75. doi: 10.1007/s10549-013-2687-7. Epub 2013 Sep 13.

2.

Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.

Ohara M, Shigematsu H, Tsutani Y, Emi A, Masumoto N, Ozaki S, Kadoya T, Okada M.

Breast. 2013 Oct;22(5):958-63. doi: 10.1016/j.breast.2013.05.003. Epub 2013 Jun 10.

PMID:
23756383
3.

Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma.

Uehara H, Tsutani Y, Okumura S, Nakayama H, Adachi S, Yoshimura M, Miyata Y, Okada M.

Ann Thorac Surg. 2013 Dec;96(6):1958-65. doi: 10.1016/j.athoracsur.2013.06.086. Epub 2013 Sep 7.

PMID:
24021765
5.

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.

Aogi K, Kadoya T, Sugawara Y, Kiyoto S, Shigematsu H, Masumoto N, Okada M.

Breast Cancer Res Treat. 2015 Feb;150(1):209-17. doi: 10.1007/s10549-015-3303-9. Epub 2015 Feb 20.

6.

Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.

Ueda S, Tsuda H, Asakawa H, Omata J, Fukatsu K, Kondo N, Kondo T, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H.

BMC Cancer. 2008 Jun 9;8:165. doi: 10.1186/1471-2407-8-165.

7.

Value of integrated positron emission tomography revised using a phantom study to evaluate malignancy grade of lung adenocarcinoma: a multicenter study.

Nakayama H, Okumura S, Daisaki H, Kato Y, Uehara H, Adachi S, Yoshimura M, Okada M.

Cancer. 2010 Jul 1;116(13):3170-7. doi: 10.1002/cncr.25244.

8.

Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.

Ueda S, Tsuda H, Asakawa H, Shigekawa T, Fukatsu K, Kondo N, Yamamoto M, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H.

Jpn J Clin Oncol. 2008 Apr;38(4):250-8. doi: 10.1093/jjco/hyn019.

PMID:
18407934
9.

Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role.

Vesselle H, Freeman JD, Wiens L, Stern J, Nguyen HQ, Hawes SE, Bastian P, Salskov A, Vallières E, Wood DE.

Clin Cancer Res. 2007 Jun 1;13(11):3255-63.

10.

Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.

Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M.

J Thorac Cardiovasc Surg. 2012 Mar;143(3):607-12. doi: 10.1016/j.jtcvs.2011.10.037. Epub 2011 Nov 20.

11.

The clinical significance of standardized uptake value in breast cancer measured using 18F-fluorodeoxyglucose positron emission tomography/computed tomography.

Kim YH, Lee JA, Baek JM, Sung GY, Lee DS, Won JM.

Nucl Med Commun. 2015 Aug;36(8):790-4. doi: 10.1097/MNM.0000000000000330.

PMID:
25932535
12.

Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography of breast cancer in detecting axillary lymph node metastasis: comparison with ultrasonography and contrast-enhanced CT.

Monzawa S, Adachi S, Suzuki K, Hirokaga K, Takao S, Sakuma T, Hanioka K.

Ann Nucl Med. 2009 Dec;23(10):855-61. doi: 10.1007/s12149-009-0314-9. Epub 2009 Oct 30.

PMID:
19876704
13.

Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma.

Okada M, Nakayama H, Okumura S, Daisaki H, Adachi S, Yoshimura M, Miyata Y.

J Thorac Cardiovasc Surg. 2011 Jun;141(6):1384-91. doi: 10.1016/j.jtcvs.2011.02.007. Epub 2011 Mar 25.

14.

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.

Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK.

Ann Intern Med. 2003 Dec 2;139(11):879-92. Review.

PMID:
14644890
15.

Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.

De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, Doyle GV, Jackson S, Andreopoulou E, Handy BC, Reuben JM, Fritsche HA, Macapinlac HA, Hortobagyi GN, Cristofanilli M.

J Clin Oncol. 2009 Jul 10;27(20):3303-11. doi: 10.1200/JCO.2008.19.4423. Epub 2009 May 18.

PMID:
19451443
16.

The preoperative maximum standardized uptake value measured by 18F-FDG PET/CT as an independent prognostic factor of overall survival in endometrial cancer patients.

Walentowicz-Sadlecka M, Malkowski B, Walentowicz P, Sadlecki P, Marszalek A, Pietrzak T, Grabiec M.

Biomed Res Int. 2014;2014:234813. doi: 10.1155/2014/234813. Epub 2014 Jan 20.

17.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
18.

FDG PET/CT evaluation of pathologically proven pulmonary lesions in an area of high endemic granulomatous disease.

Sebro R, Aparici CM, Hernandez-Pampaloni M.

Ann Nucl Med. 2013 May;27(4):400-5. doi: 10.1007/s12149-013-0695-7. Epub 2013 Feb 12.

19.

The Difference in Maximum Standardized Uptake Value among Lung Adenocarcinomas Located at the Upper and Lower Zone on PET/CT.

Yoshiya T, Miyata Y, Ibuki Y, Mimae T, Tsutani Y, Nakayama H, Okumura S, Yoshimura M, Okada M.

Respiration. 2015;90(4):293-8. doi: 10.1159/000437096. Epub 2015 Aug 12.

20.

(18)F-FDG PET/CT-positive internal mammary lymph nodes: pathologic correlation by ultrasound-guided fine-needle aspiration and assessment of associated risk factors.

Wang CL, Eissa MJ, Rogers JV, Aravkin AY, Porter BA, Beatty JD.

AJR Am J Roentgenol. 2013 May;200(5):1138-44. doi: 10.2214/AJR.12.8754.

PMID:
23617501

Supplemental Content

Support Center